Diseases, Conditions, Syndromes

New chlamydia drug targets discovered using CRISPR and stem cells

Scientists at the Wellcome Trust Sanger Institute and their collaborators at the University of British Columbia have created an innovative technique for studying how chlamydia interacts with the human immune system.

Immunology

Scientists stumble upon a model to study a lethal complication

More and more hospitalized patients with sepsis are being diagnosed with a deadly complication characterized by high levels of inflammation. A team of Yale researchers has uncovered clues to the cause of this complication—which ...

Immunology

Tuberculosis bacteria build 'edible' havens in immune cells

Bacteria that cause tuberculosis trick immune cells meant to destroy them into hiding and feeding them instead. This is the result of a study led by researchers from NYU Langone Medical Center and published online April 18 ...

HIV & AIDS

How HIV infection shrinks the brain's white matter

It's long been known that people living with HIV experience a loss of white matter in their brains. As opposed to "gray matter," which is composed of the cell bodies of neurons, white matter is made up of a fatty substance ...

Diseases, Conditions, Syndromes

Zinc discovery holds promise for people with cystic fibrosis

University of Queensland researchers have identified an opportunity to reduce infections in people living with cystic fibrosis (CF). Professor Matt Sweet, Dr. Kaustav Das Gupta and Dr. James Curson from UQ's Institute for ...

page 4 from 6